Prostacyclin release by rat cardiac fibroblasts: Inhibition of collagen expression

Hypertension

Volumn 30, Issue 5, 1997, Pages 1047-1053

  Yu, Hisahiro ^a   Gallagher, Ann Marie ^a   Garfin, Phillip M ^a   Printz, Morton P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin II; Arachidonic acid; Bradykinin; Collagen types I and III; Hypertrophy, left ventricular; Prostacyclin

Indexed keywords

BERAPROST; COLLAGEN; PROSTACYCLIN;

ANIMAL CELL; ARTICLE; COLLAGEN METABOLISM; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; FIBROBLAST; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; ICOSANOID METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL; VASCULAR SMOOTH MUSCLE;

EID: 0030695437     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1047     Document Type: Article

References (54)

1. Doering CW, Jalil JE, Janicki JS, Pick R, Agnili S, Abrahams C, Weber KT. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 1988;22:686-695.
2. Covell JW. Factors influencing diastolic function. Possible role of the extracellular matrix. Circulation. 1990;81:155-158.
3. Weber KT, Brilla CG, Janicki JS, Reddy HK, Campbell SE. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol. 1991; 86(suppl):25-31.
4. Fullerton MJ, Funder JW. Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc Res. 1994;28:1863-1867.
5. Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol. 1996:28:851-858.
6. Korn JH. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products. J Clin Invest. 1983;71: 1240-1246.
7. Klett CPR, Palmer A, Dirig DM, Gallagher A, Camacho N, Printz MP. Evidence for differences in cultured left ventricular fibroblast populations isolated from spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens. 1995;13:1421-1431.
8. Bahnson TD, Printz MP, Gallagher AM, Kim NN, Rioseco N. Angiotensin II-mediated calcium signaling in cardiac fibroblasts is species specific. Circulation. 1995;92,I-64. Abstract.
9. Pfeffer MA, Lamas GA, Vaufhan DE, Parisi AF, Braunwald AF. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;349:80-86.
10. Mukherjee D, Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Invest. 1991;88:1141-1146.
11. Tan LB, Brilla C, Weber KT. Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition. J Hypertens. 1992;10:S31-S34.
12. Dahlof B, Pennert K, Hansson L. Regression of left ventricular hypertrophy: a meta-analysis. Clin Exp Hypertens [A]. 1992;14: 173-180.
13. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25-49.
14. Schror K. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol. 1992;20(suppl 9):S68-S73.
15. Ehring T, Baumgart D, Krajcar M, Hummelgen M, Kompa S, Heusch G. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation. 1994;90:1368-1385.
16. Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbah HN, Carretero OA. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/ reperfusion injury in rats. Hypertension. 1996;27:7-13.
17. Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger T. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin. J Cardiovasc Pharmacol. 1994;24:462-469.
18. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats: lisinopril-mediated regression of myocardial fibrosis. Hypertension. 1996;28:269-275.
19. Hopkins NK, Gorman RR. Regulation of 3T3-L1 fibroblast differentiation by prostacyclin (prostaglandin 12). Biochim Biophys Acta. 1981;663:457-466.
20. Koh E, Morimoto S, Jiang B, Inoue T, Nabata T, Kitano S, Yasuda O, Fukuo K, Ogihara T. Effects of beraprost sodium, a stable analogue of prostacyclin, on hyperplasia, hypertrophy and glycosaminoglycan synthesis of rat aortic smooth muscle cells. Artery. 1993;20:242-252.
21. 2 and to express cyclooxygenase-2. J Clin Invest. 1995;95:1861-1868.
22. Goldstein RH, Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem. 1982;257:8630-8633.
23. 2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol. 1995;76:8D-13D.
24. Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension. 1993;21:900-905.
25. Harding P, Stonier C, Aber GM. Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats. Clin Sci. 1991; 81,491-497.
26. Linssen MCJG, Engels W, Lemmens PJMR, Heijnen VVTh, Bilsen MV, Reneman RS, van der Vusse GJ. Production of arachidonic acid metabolites in adult rat cardiac myocytes, endothelial cells, and fibroblast-like cells. Am J Physiol. 1993;264,H973-H982.
27. Kondo T, Inui H, Konishi F, Inagami T. Enhanced phospholipase D activity in vascular smooth muscle cells derived from spontaneously hypertensive rats. Clin Exp Hypertens. 1994;16:17-28.
28. Freeman EJ, Ferrario CM, Tallant EA. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive rats and Wistar-Kyoto rats. Am J Hypertens. 1995;8:1105-1111.
29. 1) receptors on rat cardiac fibroblasts. Circulation. 1993;88:2849-2861.
30. Gerritsen ME, Printz MP. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels. Circ Res. 1981;49:1152-1163.
31. Zhang H, Gaginella TS, Chen X, Cornwell DG. Action of bradykinin at the cyclooxygenase step in prostanoid synthesis through the arachidonic acid cascade. Agents Actions. 1991;34:397-404.
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193: 265-275.
33. Konishi F, Kondo T, Inagami T. Phospholipase D in cultured vascular smooth muscle cells and its activation by phorbol ester. Biochem Biophys Res Commun. 1991;179:1070-1076.
34. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
35. Henke DC, Kouzan S, Eling TE. Analysis of leukotriens, prostaglandins and other oxygenated metabolites of arachidonic acid by high-performance liquid chromatography. Anal Biochem. 1984;140: 87-94.
36. Patel KV, Schrey MP. Inhibition of DNA synthesis and growth in human breast stomal cells by bradykinin: evidence for independent role of B1 and B2 receptors in the respective control of cell growth and phospholipid hydrolysis. Cancer Res. 1992;52:334-340.
37. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
38. Philips N, Bashey RI, Jimenez SA. Collagen and fibronectin expression in cardiac fibroblasts from hypertensive rats. Cardiovasc Res. 1994;28:1342-1347.
39. 2 production by rat blood vessels: diminished prostacyclin formation in veins compared to arteries. Prostaglandins. 1978;16:1-16.
40. Skidgel RA, Friedman WF, Printz MP. Prostaglandin biosynthetic activities of isolated fetal lamb ductus arteriosus, other blood vessels, and lung tissue. Pediatr Res. 1983;18:12-18.
41. 2-mediated mechanism of vascular contraction in hypertensive rats. Circ Res. 1994;74:197-205.
42. Hopkins NK, Gorman RR. Regulation of 3T3-L1 fibroblast differentiation by prostacyclin (prostaglandin I2). Biochim Biophys Acta. 1981;663:457-466.
43. Hyman BT, Stoll LL, Spector AA. Prostaglandin production by 3T3-L1 cells in culture. Biochim Biophys Acta. 1982;713:375-385.
44. Lang U, Vallotton MB. Effects of angiotensin II and of phorbol ester on protein kinase C activity and on prostacyclin production in cultured rat aortic smooth-muscle cells. Biochem J. 1989;259: 477-484.
45. Lokuta AJ, Cooper C, Gaa ST, Wang HE, Rogers TB. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. J Biol Chem. 1994;269:4832-4838.
46. Schror K. Prostaglandin-mediated actions of the renin-angiotensin system. Drug Res. 1993;43:236-241.
47. Axelrod J. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochem Soc Trans. 1990;18:503-507.
48. Coyne DW, Mordhorst M, Morrison AR. Regulation of eicosanoid biosynthesis by phorbol ester in Madin Darby canine kidney cells. Am J Physiol. 1990;259:F698-F703.
49. McAllister BS, Lundberg LMFL, Javors MA, Olson MS. Bradykinin receptors and signal transduction pathways in human fibroblasts: integral role for extracellular calcium. Arch Biochem Biophys. 1993;304:294-301.
50. Lerner UH, Brunius G, Modeer T. On the signal transducing mechanisms involved in the synergistic interaction between interleukin-1 and bradykinin on prostaglandin biosynthesis in human gingival fibroblasts. Biosci Rep. 1992;12:263-271.
51. Pratt PF, Rosolowsky M, Campbell WB. Mediators of arachidonic acid-induced relaxation of bovine coronary artery. Hypertension. 1996;28:76-82.
52. Baum BJ, Moss J, Breul SD, Crystal RG. Association in normal human fibroblasts of elevated levels of adenosine 3′,5′-monophosphate with a selective decrease in collagen production. J Biol Chem. 1978;253:3391-3394.
53. Hara S, Morishita R, Tone Y, Yokoyama C, Inoue H, Kaneda Y, Ogihara T, Tanabe T. Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. Biochem Biophys Res Commun. 1995;216:862-867.
54. Ohta K, Kim S, Iwao H. Role of angiotensin-converting enzyme adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development. Hypertension. 1996;28:627-634.